Executive Chair Mark S. Ordan to Return as Chief Executive Officer Company Redoubles Strategic Focus on Physician Practices and Hospital and Health System Relationships FORT LAUDERDALE, Fla. / Jan 13, 2025 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD) (“Pediatrix” or “the Company”), a leading provider of physician services, today announced a leadership transition to accelerate its progress in executing a... Read More

FORT LAUDERDALE, Fla. / Nov 01, 2024 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported earnings of $0.23 per share for the three months ended September 30, 2024. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.44. For the 2024 third quarter, Pediatrix reported the following results: Net revenue of $511 million; Net income of $19 million; and... Read More

FORT LAUDERDALE, Fla. / Oct 16, 2024 / Business Wire / Pediatrix Medical Group, Inc . (NYSE: MD) will host an investor conference call and webcast on Friday, November 1, 2024 at 9:00 a.m. ET to discuss results from operations for the quarter ended September 30, 2024. A detailed press release will be issued the morning of November 1, 2024 before the securities markets open. The investor conference call will be webcast and can... Read More

FORT LAUDERDALE, Fla. / Aug 06, 2024 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported a loss of $1.84 per share for the three months ended June 30, 2024. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.34. For the 2024 second quarter, Pediatrix reported the following results: Net revenue of $504 million; Net loss of $153 million; and Adjusted... Read More

FORT LAUDERDALE, Fla. / Jul 18, 2024 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Tuesday, August 6, 2024 at 9:00 a.m. ET to discuss results from operations for the quarter ended June 30, 2024. A detailed press release will be issued the morning of August 6, 2024 before the securities markets open. The investor conference call will be webcast and can be... Read More

FORT LAUDERDALE, Fla. / May 22, 2024 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD) is scheduled to present at the following healthcare conferences: May 30, 2024 at 9:20 am CT at the Leerink Partners Healthcare Crossroads Conference in Austin, TX. June 6, 2024 at 7:30 am ET at the Jefferies Global Healthcare Conference in New York, NY. A link to the audio webcasts will be made available at Pediatrix’s website,... Read More

FORT LAUDERDALE, Fla. / May 07, 2024 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings of $0.05 per share for the three months ended March 31, 2024. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.20. For the 2024 first quarter, Pediatrix reported the following results: Net revenue of... Read More

FORT LAUDERDALE, Fla. / Apr 22, 2024 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Tuesday, May 7, 2024 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2024. A detailed press release will be issued the morning of May 7, 2024 before the securities markets open. The investor conference call will be webcast and can be accessed... Read More

FORT LAUDERDALE, Fla. / Feb 20, 2024 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported a loss from continuing operations of $1.50 per share for the three months ended December 31, 2023. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.32. For the 2023 fourth quarter,... Read More

High preterm birth rate underscores the importance of continuing education on the care of premature and critically ill newborns FORT LAUDERDALE, Fla. / Feb 13, 2024 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, will host the top meetings in neonatal-perinatal medicine Feb. 19-24 in Las Vegas, Nevada. Specialty Review... Read More

FORT LAUDERDALE, Fla. / Feb 07, 2024 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Tuesday, February 20, 2024 at 9:00 a.m. ET to discuss results from operations for the quarter ended December 31, 2023. A detailed press release will be issued the morning of February 20, 2024 before the securities markets open. The investor conference call will be webcast and... Read More

November is Prematurity Awareness Month, Announcement Comes in Celebration of World Prematurity Day on Friday, Nov. 17 LONG BEACH, Calif. , Nov. 16, 2023 /PRNewswire/ -- MemorialCare Miller Children's & Women's Hospital Long Beach , along with Pediatrix Medical Group , who has been a long-standing neonatology partner with... Read More

FORT LAUDERDALE, Fla. / Nov 02, 2023 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.26 per share for the three months ended September 30, 2023. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.32. For the 2023 third quarter,... Read More

FORT LAUDERDALE, Fla. / Oct 20, 2023 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, November 2, 2023 at 9:00 a.m. ET to discuss results from operations for the quarter ended September 30, 2023. A detailed press release will be issued the morning of November 2, 2023 before the securities markets open. The investor conference call will be webcast and... Read More

FORT LAUDERDALE, Fla. / Aug 03, 2023 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.34 per share for the three months ended June 30, 2023. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.39. For the 2023 second quarter,... Read More

FORT LAUDERDALE, Fla. / Jul 18, 2023 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, August 3, 2023 at 9:00 a.m. ET to discuss results from operations for the quarter ended June 30, 2023. A detailed press release will be issued the morning of August 3, 2023 before the securities markets open. The investor conference call will be webcast and can be... Read More

FORT LAUDERDALE, Fla. / May 04, 2023 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today announced that its board of directors has appointed Sylvia Young, a recognized leader in healthcare and long-term healthcare executive, as an independent director, effective May 12, 2023. Ms. Young, a veteran of hospital... Read More

FORT LAUDERDALE, Fla. / May 03, 2023 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD) today announced that it will present on Tuesday, May 9, 2023 at 5:00 pm PT to investors attending the 2023 Bank of America Health Care Conference in Las Vegas, Nevada. The presentation will be broadcast through live audio webcast and can be accessed at Pediatrix’s website, www.pediatrix.com/investors . ABOUT PEDIATRIX MEDICAL... Read More

FORT LAUDERDALE, Fla. / May 02, 2023 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.17 per share for the three months ended March 31, 2023. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.23. For the 2023 first quarter,... Read More

FORT LAUDERDALE, Fla. / Apr 26, 2023 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Tuesday, May 2, 2023 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2023. A detailed press release will be issued the morning of May 2, 2023 before the securities markets open. The investor conference call will be webcast and can be accessed... Read More

FORT LAUDERDALE, Fla. / Mar 08, 2023 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD) today announced that its board of directors has elected James D. Swift, M.D., the Company’s chief executive officer, as a director effective March 8, 2023. This appointment fills a seat previously held by Roger J. Medel, M.D. “Jim’s election follows his recent appointment as chief executive officer,” said Mark S. Ordan, executive... Read More

FORT LAUDERDALE, Fla. / Feb 21, 2023 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, babies and children, will host the top meeting in neonatal medicine Feb. 22-24 in Las Vegas, Nevada. More than 385 physicians, allied health professionals, advanced practitioners/registered nurses, residents/fellows and exhibitors are expected to attend... Read More

FORT LAUDERDALE, Fla. / Feb 17, 2023 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.29 per share for the three months ended December 31, 2022. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.47. For the 2022 fourth quarter,... Read More

FORT LAUDERDALE, Fla. / Feb 06, 2023 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Friday, February 17, 2023 at 9:00 a.m. ET to discuss results from operations for the quarter ended December 31, 2022. A detailed press release will be issued the morning of February 17, 2023 before the securities markets open. The investor conference call will be webcast and can... Read More